You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intermediate-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Uveitis Posterior Non-Infectious, Uveitis, Intermediate, Noninfectious Panuveitis Trial in Waltham, Erie (ESK-001)

Recruiting
  • Uveitis Posterior Non-Infectious
  • +2 more
  • Waltham, Massachusetts
  • +1 more
Jul 18, 2023

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 24, 2023

MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

Not yet recruiting
  • MDS
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2021

HSV Trial (Pritelivir)

Available
  • HSV
  • (no location specified)
Apr 25, 2023

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022

Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial (Ozurdex 0.7mg Ophthalmic Implant, Prednisone)

Recruiting
  • Uveitis, Posterior
  • +2 more
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute - Vision Research Centre
Dec 14, 2022

Dentofacial Deformities, Le Fort; I Trial in Alexandria (Orthognathic surgery (lefort1))

Completed
  • Dentofacial Deformities
  • Le Fort; I
  • Orthognathic surgery (lefort1)
  • Alexandria, Egypt
    Alexandria University, Faculty of dentistry
Nov 9, 2023

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, Tremelimumab (Cohort A

Recruiting
  • Intermediate Stage of Hepatocellular Carcinoma
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Oct 6, 2022

Colorectal Cancer, Colonic Polyp Trial in Nijmegen (Plenvu, Moviprep)

Recruiting
  • Colorectal Cancer
  • Colonic Polyp
  • Nijmegen, Gelderland, Netherlands
    Radboud university medical center
Aug 8, 2022

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Rectal Cancer Trial in Guangzhou (Sintilimab)

Recruiting
  • Rectal Cancer
  • Guangzhou, Guangdong, China
    Department of colorectal surgery, the Sixth Affiliated Hospital,
Jul 11, 2022

Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
Jan 12, 2022

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1, EBV-DNA=4000 Copy/ml Trial in Guangzhou (Toripalimab, IMRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Yanqun Xiang
Feb 7, 2022

Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022

Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Trial (Triheptanoin)

Available
  • Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
  • (no location specified)
Nov 22, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Prostate Cancer Trial in Greenfield Park (HDR brachytherapy as monotherapy)

Completed
  • Prostate Cancer
  • HDR brachytherapy as monotherapy
  • Greenfield Park, Quebec, Canada
    Hôpital Charles LeMoyne
Mar 15, 2022

Cardiology, Coronary Artery Disease Trial (Coronary CT in 1st line compared to the strategy with functional test in 1st line in

Not yet recruiting
  • Cardiology
  • Coronary Artery Disease
  • Coronary CT in 1st line compared to the strategy with functional test in 1st line in patient at Intermediate Risk of Developing Stable Coronary Disease:
  • (no location specified)
May 5, 2022

Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Nov 4, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022